A real-world drug utilization study assessing patient characteristics of new initiators of glycopyrronium bromide.
Phase of Trial: Phase IV
Latest Information Update: 03 Jan 2017
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 03 Jan 2017 New trial record